DOMINION DIAGNOSTICS, LLC
NORTH KINGSTON, RI

Dominion Diagnostics, LLC, established in 1997, primarily serves the medical field by offering clinical drug monitoring solutions alongside innovative support services tailored to various medical specialties. The company is rooted in Addiction Medicine, leveraging quantitative urine drug testing as a core diagnostic tool to enhance patient treatment outcomes. Over its growth trajectory, Dominion Diagnostics assembled a team dedicated to elevating the standard of healthcare through strategic and compliant clinical information. The organization is headquartered at 211 Circuit Drive, North Kingstown, RI, with the incorporation in Florida under filed number M09000001958 on May 21, 2009. Recognized for its comprehensive regulatory compliance measures—including adherence to FDA Opioid REMS—Dominion Diagnostics maintains national and regional network provider status for over 80% of commercial lives served across the US. Guided by CEO Robert M. Garvey Jr., who also chairs the Coalition for Excellence in Medication Monitoring (CEMM), the company focuses on advancing medication monitoring standards. Mark A. McSally, Esq. serves as Chief Operating Officer and General Counsel since his transition from Outside General Counsel in 2006. The leadership team is rounded out by industry experts such as Arthur Brookfield, Ken F. Indof, Mary P. Hauser, Dr. Charlene Johnson, David J. Molusis, and Sheri Machado, who collectively bring over seven decades of combined experience across healthcare diagnostics, IT, human resources, addiction medicine, behavioral health, and financial management. Dominion Diagnostics is trusted for its effective integration of actionable clinical data that supports patient care advancement through responsible monitoring programs. Notably, the company collaborates with institutions like the American Society of Addiction Medicine (ASAM) to uphold best practices in opioid use disorder treatment via evidence-based guidelines. As a testament to its longstanding presence and reliability, Dominion Diagnostics remains actively compliant as evidenced by recent reports filed, ensuring continued excellence in service delivery.